Green, D J
Bensinger, W I
Holmberg, L A
Gooley, T
Till, B G
Budde, L E
Pagel, J M
Frayo, S L
Roden, J E
Hedin, L
Press, O W
Gopal, A K
Article History
Received: 19 November 2015
Revised: 23 March 2016
Accepted: 29 March 2016
First Online: 23 May 2016
Competing interests
: Research funding was provided by Teva Pharmaceuticals for this investigator-initiated research study. The funding was used to support the salaries of research study staff. Bendamustine was provided to patients by Teva Pharmaceuticals at no cost. Teva Pharmaceuticals played no role in the study design, the collection and analysis of the data the decision to publish this work or the writing of this manuscript. Drs Green, Gopal and Budde have received research support from Teva Pharmaceuticals. Dr Pagel has received compensation as a consultant to Teva Pharmaceuticals. The authors have no personal financial interests in Teva Pharmaceuticals and declare no other conflict of interest.